Glenmark Pharmaceuticals Ltd. - an international, integrated pharmaceutical company based activities that - research and development of innovative medicines preparatov.Glenmark is a leading player in the development of new molecules: NHS (new chemical compound) and NBS (new biological compound). To date, eight molecules in various stages of clinical development. The company occupies a significant place in the market of generic drugs in emerging economies, including India. Division of the company, Glenmark Dzheneriks Co., Ltd. has grown rapidly and occupies a strong position in the generics market in the US. The division also provides APIs (active pharmaceutical ingredients) to regulate and floor Regulated rynki.Bolee 6,000 people in 80 countries are working in the company of Glenmark. Glenmark has twelve factories, which are located in four countries and five research tsentrami.V 2008, Glenmark has received awards for the 2nd SCRIP Award nominations: "The best pharmaceutical company in the world" (among small and medium-sized companies) and "Best the company in emerging markets. " SCRIP - a leading global pharmaceutical journal. SCRIP Award is one of the most prestigious international pharmaceutical premiums. Results to December 10, 2008 in London, UK were announced. In the same year, Forbes, another leading publication, honored Glenmark company award in the nomination "The best company with a turnover of up to a billion dollars in the Asia-Pacific region."